These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15851720)

  • 1. Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine.
    Cherner M; Letendre S; Heaton RK; Durelle J; Marquie-Beck J; Gragg B; Grant I;
    Neurology; 2005 Apr; 64(8):1343-7. PubMed ID: 15851720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple trouble: cognitive deficits from hepatitis C, HIV, and methamphetamine.
    van Gorp WG; Hinkin CH
    Neurology; 2005 Apr; 64(8):1328-9. PubMed ID: 15851716
    [No Abstract]   [Full Text] [Related]  

  • 3. Cognitive function in HIV-seropositive Nigerians without AIDS.
    Salawu FK; Bwala SA; Wakil MA; Bani B; Bukbuk DN; Kida I
    J Neurol Sci; 2008 Apr; 267(1-2):142-6. PubMed ID: 18001772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive deleterious effects of methamphetamine dependence and immunosuppression on neuropsychological functioning in HIV infection.
    Carey CL; Woods SP; Rippeth JD; Gonzalez R; Heaton RK; Grant I
    AIDS Behav; 2006 Mar; 10(2):185-90. PubMed ID: 16477511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of neuropsychological functioning and depressed mood on functional complaints in HIV-1 infection and methamphetamine dependence.
    Sadek JR; Vigil O; Grant I; Heaton RK;
    J Clin Exp Neuropsychol; 2007 Apr; 29(3):266-76. PubMed ID: 17454347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dementia and neurocognitive disorders due to HIV-1 infection.
    Ances BM; Ellis RJ
    Semin Neurol; 2007 Feb; 27(1):86-92. PubMed ID: 17226745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus co-infection increases neurocognitive impairment severity and risk of death in treated HIV/AIDS.
    Vivithanaporn P; Nelles K; DeBlock L; Newman SC; Gill MJ; Power C
    J Neurol Sci; 2012 Jan; 312(1-2):45-51. PubMed ID: 21925684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.
    Mohsen AH; Murad S; Easterbrook PJ
    HIV Med; 2005 May; 6(3):206-15. PubMed ID: 15876288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection.
    Parsons TD; Tucker KA; Hall CD; Robertson WT; Eron JJ; Fried MW; Robertson KR
    AIDS; 2006 Aug; 20(12):1591-5. PubMed ID: 16868439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors.
    McAndrews MP; Farcnik K; Carlen P; Damyanovich A; Mrkonjic M; Jones S; Heathcote EJ
    Hepatology; 2005 Apr; 41(4):801-8. PubMed ID: 15793853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychiatric HIV-1 infection study: in Kenya and Zaire cross-sectional phase I and II.
    Sebit MB
    Cent Afr J Med; 1995 Oct; 41(10):315-22. PubMed ID: 8556777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive deficits and degeneration of interneurons in HIV+ methamphetamine users.
    Chana G; Everall IP; Crews L; Langford D; Adame A; Grant I; Cherner M; Lazzaretto D; Heaton R; Ellis R; Masliah E;
    Neurology; 2006 Oct; 67(8):1486-9. PubMed ID: 17060582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methamphetamine, the brain, HIV, and mental health.
    Jones K
    Focus; 2005 Jul; 20(6):1-5. PubMed ID: 16110566
    [No Abstract]   [Full Text] [Related]  

  • 14. Alterations in the hemodynamic response function in cognitively impaired HIV/AIDS subjects.
    Juengst SB; Aizenstein HJ; Figurski J; Lopez OL; Becker JT
    J Neurosci Methods; 2007 Jul; 163(2):208-12. PubMed ID: 17540453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus infection among methamphetamine-dependent individuals in outpatient treatment.
    Gonzales R; Marinelli-Casey P; Shoptaw S; Ang A; Rawson RA
    J Subst Abuse Treat; 2006 Sep; 31(2):195-202. PubMed ID: 16919748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus seropositivity in a South African Cohort of HIV co-infected, ARV naïve patients is associated with renal insufficiency and increased mortality.
    Parboosing R; Paruk I; Lalloo UG
    J Med Virol; 2008 Sep; 80(9):1530-6. PubMed ID: 18649335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating health-related quality of life, mood and neuropsychological test performance in a homogeneous cohort of Irish female hepatitis C patients.
    Lowry D; Coughlan B; McCarthy O; Crowe J
    J Viral Hepat; 2010 May; 17(5):352-9. PubMed ID: 19758275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methamphetamine use and HIV risk behaviors among heterosexual men--preliminary results from five northern California counties, December 2001-November 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Mar; 55(10):273-7. PubMed ID: 16543881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients.
    Shores NJ; Maida I; Soriano V; Núnez M
    J Hepatol; 2008 Sep; 49(3):323-8. PubMed ID: 18486266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons.
    Rippeth JD; Heaton RK; Carey CL; Marcotte TD; Moore DJ; Gonzalez R; Wolfson T; Grant I;
    J Int Neuropsychol Soc; 2004 Jan; 10(1):1-14. PubMed ID: 14751002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.